Business Wire

CA-PACSCI-EMC

17.3.2020 15:02:07 CET | Business Wire | Press release

Share
Pacific Scientific Energetic Materials Company Signs MOU with Space Information Laboratories to Provide Plug-and-Play Autonomous Flight Safety System (AFSS)

Pacific Scientific Energetic Materials Company (California), LLC. (PacSci EMC) announced today the execution of a Memorandum of Understanding with Space Information Laboratories (SIL) to provide plug-and-play Autonomous Flight Termination Systems (AFTS) for launch vehicles, missiles, hypersonic vehicles, reentry vehicles, strike weapons and unmanned aerial systems. PacSci EMC Safe and Arm high voltage electronics will be integrated with the SIL Vehicle Based Independent Tracking System (VBITS) AFTU with internal GPS L1/L2 Receivers, IMU, together in a Consolidated Avionics® unit with reduced Space, Weight and Power (SWAP) requirements. Attributes include open, modular, stackable and reconfigurable (OMSR) avionics.

“SIL has very unique, leading-edge technology for the AFSS mission that when combined with the PacSci EMC flight qualified ordnance flight termination system provides a low cost, comprehensive solution for this critical need,” said Greg Scaven, President, PacSci EMC. “The AFSS architecture is RCC-319 compliant with the flexibility and safety necessary for platform success, and the system can be customized for unique applications.”

SIL is a leading provider of high-end Li-Ion Polymer Intelli-Pack® Avionics/Telemetry and FTS Batteries, VBITS GPS Tracking and Autonomous Flight Termination Systems (AFTS), Space Based Range, and Consolidated Avionics® flight units for DoD programs of national significance. Originally developed in 2006, VBITS has successfully flown many times without loss of GPS receiver lock and this heritage is being leveraged. SIL’s patented Vehicles Based Independent Range System (VBIRS) will track, destroy and send high data rate BLOS telemetry without the need for ground range instrumentation Radar, Flight Termination and/or Telemetry Systems, and thus greatly reduces launch, and weapon system test and evaluation, costs.

Edmund Burke, President of Space Information Laboratories, said: “I am very impressed with PacSci EMC’s broad product offering and technical capabilities. They rapidly filled a need for us that will result in accelerated growth.”

About Pacific Scientific Energetic Materials Co.

PacSci EMC provides state-of-the-art safe and arm high voltage electronics firing circuitry for multiple DoD and commercial launch vehicle, missile, weapons and aircraft. PacSci EMC missile control safety and arming products are suitable for application in all weapon systems. PacSci EMC has seven decades of pyrotechnic and energetic materials experience for mission and flight critical safety systems. (https://psemc.com )

About Space Information Laboratories

Headquartered in Santa Maria, CA near Vandenberg AFB, SIL is a world-class small business supplier of innovative avionics and power system technologies and solutions for mission-critical programs for the MDA, NAVAIR, USAF, DARPA, Aerospace Industry, and other U.S. Government Agencies. SIL’s expertise includes development and production of Li-Ion Polymer Intelli-Pack® batteries, Intelli-Avionics®, VBITS GPS Tracking and Autonomous Flight Termination System, Space Based Range and Chameleon 12U to 27U Flexible Bus product lines. SIL is AS9100D Quality Management System certified to design, manufacture and test flight units. (www.spaceinformationlabs.com )

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SLB to Acquire Kelvion, Expanding its Role Across Data Center Infrastructure31.8.2026 12:50:00 CEST | Press release

Scalable, energy-efficient and reliable thermal management technologies will optimize operating performance in increasingly complex data centers and industrial systems SLB (NYSE: SLB) today announced it has signed an agreement to acquire Kelvion, a global provider of thermal management and heat exchange technologies. The acquisition strengthens SLB's Data Center Solutions business with critical thermal management technologies and expands the company's role in data center infrastructure, which is one of the world’s fastest-growing industrial and technology markets. “AI is driving the most significant infrastructure investment cycle in our lifetime,” said Olivier Le Peuch, chief executive officer of SLB. “This transaction accelerates our ambition to become an industrial technology partner to the data center industry and help customers address the growing infrastructure complexity required to scale AI. Kelvion advances our path toward more integrated data center infrastructure solutions,

BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer31.8.2026 12:00:00 CEST | Press release

Findings provide further evidence of overall survival benefit of TEVIMBRA plus ZIIHERA and chemotherapy regimen in HER2+ GEAZIIHERA plus chemotherapy demonstrated statistically significant overall survival benefit at second interim analysis of HERIZON-GEA-01 trial BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the second interim analysis (IA2) of the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), in combination with chemotherapy, with and without TEVIMBRA® (tislelizumab), as first-line treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). At IA2, ZIIHERA plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared with trastuzumab plus chemotherapy, meeting the remaining primary endpoint analysis of the study. IA2 also provided longer follow-up data for the TEVIMBRA plus ZIIHERA

GigaDevice Strengthens EMEA and Southeast Asia Market Reach Through Strategic Partnership with Rutronik31.8.2026 09:00:00 CEST | Press release

GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, today announced a new strategic franchise partnership with Rutronik Elektronische Bauelemente GmbH, one of Europe’s leading broadline distributors of electronic components. The agreement covers EMEA and Southeast Asia, including India, and provides customers with broader access to GigaDevice’s comprehensive portfolio of microcontrollers, sensors, and power management solutions. The partnership further strengthens GigaDevice’s distribution network and local market presence across key regions. With its strong presence across Europe and growing coverage in Southeast Asia, Rutronik provides GigaDevice with an established channel supported by extensive market reach, technical expertise, and customer relationships. The collaboration will help expand access to GigaDevice’s embedded solutions across a broad range of applications and industries, including indus

Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press release

–Late-Breaking Prespecified Subgroup Analysis of HELIOS-B Demonstrates that Vutrisiran Provided Consistent Clinical Benefit Across All-Cause Mortality and Recurrent Cardiovascular Events in Patients With or Without Tafamidis Use at Baseline ––Additional Post Hoc Analyses Highlight Positive Impact of Vutrisiran in Addressing the Multisystemic Manifestations of ATTR-CM ––Pooled Analysis Across Four Positive Phase 3 Studies of Vutrisiran and Patisiran Shows Consistent Treatment Effect Across Sexes ––New Subgroup Analysis from KARDIA-3 Phase 2 Study of Zilebesiran Highlights Potential to Provide Enhanced Blood Pressure Control – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR)

New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release

Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye